Jonathon Carll
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Response to: 'Methodological concerns on prostate-specific membrane antigen (PSMA) immunohistochemistry for predicting PSMA-PET avidity'.
Journal: BJU international
Published: May 28, 2026
Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications.
Journal: World journal of urology
Published: May 26, 2026
Guideline of guidelines: pelvic lymph node dissection at time of radical prostatectomy.
Journal: BJU international
Published: April 13, 2026
Prostate-specific membrane antigen (PSMA)-PET-avid prostate cancers show stronger PSMA immunohistochemistry staining on biopsy cores.
Journal: BJU international
Published: March 18, 2026
PSMA PET in Active Surveillance: Initial Experiences and Future Directions.
Journal: Cancers
Published: March 15, 2026
A 24-Year Analysis of Percutaneous Renal Biopsy Trends in Australia.
Journal: Medical sciences (Basel, Switzerland)
Published: December 09, 2025
The role of PSMA PET/CT in staging patients with intermediate-risk prostate cancer.
Journal: BJU international
Published: September 30, 2025
Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate-risk prostate cancer.
Journal: BJU international
Published: July 24, 2025
Prostate specific membrane antigen (PSMA) as a biomarker in early and localized advanced prostate cancer: a narrative review.
Journal: The Canadian journal of urology
Published: June 10, 2025
PSMA PET as a Tool for Active Surveillance of Prostate Cancer-Where Are We at?
Journal: Journal of clinical medicine
Published: April 21, 2025
Showing 1-10 of 10
Last Updated: 09/26/2026